Merit Med Sys Inc Stock Price, News & Analysis

Merit Medical Systems (NASDAQ: MMSI) has initiated its pivotal WAVE Study to assess the safety and effectiveness of the WRAPSODY Endovascular Stent Graft for treating dialysis outflow circuit stenosis or occlusion. The first two patients have been enrolled at RAC Surgery Center, Raleigh, NC. This multicenter study aims to recruit 357 patients across the U.S., Europe, Canada, and New Zealand, with a two-year follow-up. The WRAPSODY system, already holding a CE Mark, is designed to improve vascular access in over two million global hemodialysis patients, addressing common complications in dialysis procedures.

Merit Medical Systems reported Q4 2020 revenue of $258.0 million, nearly flat compared to Q4 2019. The company experienced a 1.0% decline in core revenue on a constant currency basis. The Q4 GAAP EPS stood at $0.27, recovering from a loss of ($0.08) the previous year. Non-GAAP EPS rose to $0.54 from $0.40. For the full year, revenue was $963.9 million, down 3.1%, while GAAP net income for Q4 was $15.4 million. Merit forecasts 2021 revenue between $990 million and $1.01 billion, reflecting a cautious optimism for recovery.

Merit Medical Systems (NASDAQ: MMSI) will announce its fourth quarter and year-end financial results for 2020 on February 24, 2021, after the market closes. Investors can participate in a conference call on the same day at 5:00 p.m. Eastern via telephone or live webcast. The company specializes in manufacturing disposable medical devices for cardiology, radiology, oncology, and other therapeutic areas. With approximately 6,000 employees globally, Merit has a strong presence in various countries, including the USA, France, and China.

Merit Medical Systems (NASDAQ: MMSI) announced its participation in the 2021 SVB Leerink Global Healthcare Conference.

The conference will be held virtually on February 25, 2021, at 2:20 p.m. ET. CEO Fred P. Lampropoulos and CFO Raul Parra will present and host one-on-one meetings.

Founded in 1987, Merit specializes in manufacturing disposable medical devices for various medical fields, employing approximately 6,000 individuals worldwide.

Merit Medical Systems, a leading manufacturer of disposable medical devices, announced participation in two upcoming virtual investor conferences. On January 13, at 2:00 p.m. ET, CEO Fred P. Lampropoulos and CFO Raul Parra will present at the 23rd Annual Needham Growth Conference. The following day, January 14, at 2:30 p.m. ET, they will host a fireside chat at the ICR Conference 2021. Both events will include virtual one-on-one meetings with investors.

SOUTH JORDAN, Utah, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems (NASDAQ: MMSI) will hold an investor call today to discuss multi-year financial targets from 2020 to 2023. Key targets include a compound annual growth rate (CAGR) of 5%-7% in revenue, a GAAP operating margin of 13.7%-17.0%, and a non-GAAP operating margin of 18%-21%. The company estimates 2020 net revenue between $950 million and $959 million, a decline from $994.9 million in 2019. GAAP net loss is forecasted between $(11.8) million and $(15.0) million.

Merit Medical Systems reports Q3 2020 revenue of $244.0 million, a 0.4% increase from Q3 2019. Core revenue fell (0.1)% on a constant currency basis, while GAAP loss per share improved to $(0.05), from $(0.06). Non-GAAP EPS rose 50% to $0.42. GAAP gross margin decreased from 42.8% to 41.8%, but non-GAAP gross margin fell from 48.1% to 47.0%. Cash on hand increased to $44.6 million, with long-term debt down to $358 million. Fiscal 2020 revenue guidance is estimated at $950-$959 million, reflecting a 3.5%-4.5% annual decline.

Merit Medical Systems (NASDAQ: MMSI) announced a settlement with the U.S. Department of Justice and Health and Human Services, opting to pay $18 million to avoid litigation costs. The settlement does not imply wrongdoing, as Merit denies the allegations. The company aims to refocus on its core mission of customer service in healthcare.

Founded in 1987, Merit specializes in proprietary disposable medical devices for various medical procedures, serving hospitals globally with a workforce of around 6,000 personnel across numerous locations.

Merit Medical Systems (NASDAQ: MMSI) announces financial results for Q3 2020 on October 28, 2020, after market close. An investor call will follow on November 10, 2020, to introduce multi-year financial targets for growth and profitability. The company, a major player in medical devices for cardiology, oncology, and other sectors, will host a Q&A session during the investor call, accessible via phone and live webcast.